Lv3
370 积分 2025-02-24 加入
The Mechanisms of Action of PPARs
4小时前
已完结
NASH field celebrates ‘hurrah moment’ with a first FDA drug approval for the liver disease
18小时前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1天前
已完结
Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis
4天前
已完结
Therapeutic siRNA Loaded to RISC as Single and Double Strands Requires an Appropriate Quantitative Assay for RISC PK Assessment
4个月前
已完结
皖公网安备34019202002308
